Recro Pharma Story

Under 67% of Recro Pharma's investor base is looking to short. The analysis of current outlook of investing in Recro Pharma suggests that many traders are alarmed regarding Recro Pharma's prospects. Recro Pharma's investor sentiment overview provides quick insight into current market opportunities from investing in Recro Pharma. The current market sentiment, together with Recro Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Recro Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Recro Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Recro daily returns and investor perception about the current price of Recro Pharma as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Recro Pharma.

Recro Pharma Latest Timeline

Recro Pharma is listed for 0.00. About 65.0% of the company shares are owned by institutional investors. The book value of Recro Pharma was at this time reported as 0.95. The company recorded a loss per share of 0.57. Recro Pharma had not issued any dividends in recent years. The entity had a split on the 22nd of November 2019.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Consideration for investing in Recro Stock

If you are still planning to invest in Recro Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Recro Pharma's history and understand the potential risks before investing.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stocks Directory
Find actively traded stocks across global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Transaction History
View history of all your transactions and understand their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Valuation
Check real value of public entities based on technical and fundamental data